JenaValve Appoints Duane Pinto, MD, MPH, as Chief Medical
IRVINE, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve...
Source: globenewswire.com
Page 2 - Trilogy System News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Trilogy System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Trilogy System Today - Breaking & Trending Today
JenaValve completes enrollment in TAVR trial
JenaValve announced today that it successfully completed patient enrollment in a trial evaluating its Trilogy heart valve system.
Source: massdevice.com
JenaValve Raises $100M in Series C Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
JenaValve Technology Receives CE Mark for its Trilogy™ TAVI
JenaValve Technology Receives CE Mark for its Trilogy™ TAVI System for the Treatment of Aortic Regurgitation and Aortic Stenosis May 25, 2021 08:00 ET | Source: JenaValve Technology, Inc. JenaValve Technology, Inc. Irvine, California, UNITED STATES IRVINE, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer, and manufacturer of differentiated transcatheter aortic valve implantation (TAVI) systems (also referred to as TAVR, or transcatheter aortic valve replacement) for the treatment of aortic valve disease, today annou...
Source: globenewswire.com
JenaValve Technology Receives CE Mark for its Trilogy TAVI System for the Treatment of Aortic Regurgitation and Aortic Stenosis
IRVINE, Calif., May 25, 2021 — JenaValve Technology, Inc., developer, and manufacturer of differentiated transcatheter aortic valve implantation (TAVI) systems (also referred to as TAVR, or transcatheter aortic valve replacement) for the treatment of aortic valve disease, today announced that it has received CE Mark for its Trilogy™ Heart Valve System for the treatment of both aortic regurgitation (AR), also known as aortic insufficiency (AI), and aortic stenosis (AS).
Source: cathlabdigest.com